B

BridgeBio Pharma
D

BBIO

55.510
USD
0.70
(1.28%)
مغلق
حجم التداول
67,133
الربح لكل سهم
-3
العائد الربحي
-
P/E
-13
حجم السوق
10,611,763,657
أصول ذات صلة الأخبار المقالات

العنوان: BridgeBio Pharma

القطاع: Healthcare
الصناعة: Biotechnology
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.